- Home
- HURA vs HUCK Comparison
HURA vs HUCK Comparison
Compare HURA & HUCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.99
Company Overview
Basic Information| Metric | HURA | HUCK |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 159.5M |
| IPO Year | 2010 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HURA | HUCK |
|---|---|---|
| Price | $1.74 | $2.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $8.04 | $4.17 |
| AVG Volume (30 Days) | 211.8K | ★ 700.5K |
| Earning Date | 11-13-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.93 | 31.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $318,857,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $0.41 | $3.03 |
| 52 Week High | $3.43 | $3.55 |
Technical Indicators
Market Signals| Indicator | HURA | HUCK |
|---|---|---|
| Relative Strength Index (RSI) | 32.21 | 18.18 |
| Support Level | $1.27 | N/A |
| Resistance Level | $1.83 | $3.45 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 5.23 | 1.75 |
Price Performance
Historical Comparison HURA
HUCK
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.